Lumexa Imaging Holdings, Inc. (LMRI) Fair Value 2026

LMRI · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.5 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-31, Lumexa Imaging Holdings, Inc. (LMRI) trades at $11.67, versus a $21.35 median fair value across its 2 active models — 82.9% above the current price. QOC: 3.5/10. Value Trap Risk: 0/100 (SAFE). 2/13 models active.

Key Facts

Ticker
LMRI
Price
$11.67
Quality Score
3.5/10
Value Trap Risk
0/100
Models Active
2/13
Last Updated
Strength: Regime Cross-Sectional suggests +135.9% upside with 12% confidence
Risk: Below-average Quality Score of 3.5/10 signals weak fundamentals

Is Lumexa Imaging Holdings, Inc. (LMRI) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Lumexa Imaging Holdings, Inc. (LMRI) appears undervalued as of : the median of 2 independent fair value estimates is $21.35, 82.9% above the current price of $11.67. Estimates range from $15.17 to $27.53. LMRI scores 3.5/10 on fundamental quality and 0/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.1% versus its own 13-model consensus, across 3,804 rated companies as of 2026-08-31. LMRI’s +82.9% gap is wider than that market norm, and the Medical Devices sector median is -42.6%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Lumexa Imaging Holdings, Inc. Stock in 2026? →

What Fair Value Does Each Model Give LMRI?

2 Intrinsic Value Models vs. Current Price ($11.67)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Low Conviction
 $27.53 +135.9%
Option-Based · Low Conviction
 $15.17 +30.0%

All Models Active

All 2 models are displayed above.

What Is Lumexa Imaging Holdings, Inc. (LMRI) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Lumexa Imaging Holdings, Inc. is potentially undervalued at its current price of $11.67. Based on our 13-model framework, Lumexa Imaging Holdings, Inc.'s intrinsic value is estimated at a median fair value of $21.35 — representing +82.9% implied upside — with 2 out of 2 active models confirming this thesis. Model dispersion is worth noting: Regime Cross targets $27.53 (+135.9%), versus PWERM at $15.17 (+30.0%). This +105.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About LMRI?

2 of 13 models are currently active for LMRI. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for LMRI is $21.35 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does LMRI Rank in Medical Devices?

Among 159 Medical Devices stocks, LMRI ranks #153 by Quality of Company score. CirclFi's QOC score of 3.5/10 evaluates 32 fundamental signals. A score of 3.5 signals below-average fundamentals.

See all Most Undervalued Medical Devices Stocks →

Lumexa Imaging Holdings, Inc.'s positioning within the Medical Devices segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.

Is LMRI a Value Trap?

CirclFi's Value Trap algorithm assigns LMRI a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Lumexa Imaging Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Lumexa Imaging Holdings, Inc. earns a quality score of 3.5/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +105.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LMRI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LMRI's 2 active models, average confidence is 8%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Lumexa Imaging Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

GCTKGlucoTrack, Inc.QOC 3.6RTGNRetinalGenix Technologies Inc.QOC 3.5ODYYOdyssey Health, Inc.QOC 3.7WOKWORK Medical Technology Group LTDQOC 2.8STMESTIMCELL ENERGETICS INC.QOC 3.7ICCMIceCure Medical LtdQOC 2.8AXGNAxogen, Inc.QOC 7.6BFLYButterfly Network, Inc.QOC 6.4LUCDLucid Diagnostics Inc.QOC 5.5IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: GCTK · RTGN · ODYY · WOK · STME · ICCM · AXGN · BFLY · LUCD · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to LMRI?

7 companies across all industries closest to LMRI’s Quality of Company score of 3.5/10.

ATMHAll Things Mobile Analytic Inc.QOC 3.5SUNDSundance Strategies, Inc.QOC 3.5MGTIMGT Capital Investments, Inc.QOC 3.5SKFGStark Focus Group, Inc.QOC 3.5GTCHGBT Technologies Inc.QOC 3.5BTGOBitGo Holdings, Inc.QOC 3.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: ATMH · SUND · MGTI · SKFG · GTCH · BTGO · NVDA

Where Does LMRI Sit in CirclFi's Medical Devices Rankings?

LMRI is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Lumexa Imaging Holdings, Inc.’s Valuation?

What is Lumexa Imaging Holdings, Inc.'s intrinsic value in 2026?

CirclFi puts Lumexa Imaging Holdings, Inc. (LMRI)'s intrinsic value at $21.35 — the median of 2 independent model estimates as of 2026-08-31, ranging from $15.17 to $27.53. The Quality of Company score is 3.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LMRI overvalued or undervalued right now?

At $11.67, 2 of 2 active models suggest LMRI may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $21.35, 82.9% above the current price of $11.67 — a consensus view that LMRI is undervalued. The assessment depends on which methodology best fits Lumexa Imaging Holdings, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 3.5 mean for LMRI?

Lumexa Imaging Holdings, Inc.'s QOC of 3.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on LMRI?

CirclFi analyzes LMRI with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is LMRI a value trap in 2026?

Lumexa Imaging Holdings, Inc.'s Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Lumexa Imaging Holdings, Inc. (LMRI) has a median fair value of $21.35 — 82.9% above the current price of $11.67 — as of 2026-08-31.” Source: circlfi.com/stock/LMRI/ · Methodology
Primary sources for this LMRI valuation
  • Financial statements: Lumexa Imaging Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0002071288) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for LMRI as of ; valuations recomputed .